4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-15-086853
CIK 0000827871operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:47 PM ET
Size
6.8 KB
Accession
0001209191-15-086853
Insider Transaction Report
Form 4
FLAUM SANDER A
Director
Transactions
- Sale
Common Stock
2015-03-20$42.00/sh−9,800$411,600→ 19,599 total - Sale
Common Stock
2015-12-22$93.75/sh−3,225$302,360→ 16,374 total
Footnotes (2)
- [F1]These shares were sold pursuant to a prospectus filed on March 17, 2015 with the Securities and Exchange Commission.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $93.73 to $93.7563, inclusive. The reporting person undertakes to provide to Eagle Pharmaceuticals, Inc., any security holder of Eagle Pharmaceuticals, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:47 PM ET
- Size
- 6.8 KB